Apollo Endosurgery ROA 2006-2018 | APEN
Current and historical return on assets (ROA) values for Apollo Endosurgery (APEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Apollo Endosurgery ROA for the three months ending June 30, 2018 was -27.54%.
| Apollo Endosurgery ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2018-06-30 | $-0.03B | $0.11B | -27.65% |
| 2018-03-31 | $-0.03B | $0.10B | -26.34% |
| 2017-12-31 | $-0.03B | $0.11B | -27.14% |
| 2017-09-30 | $-0.03B | $0.11B | -33.76% |
| 2017-06-30 | $-0.04B | $0.09B | -51.25% |
| 2017-03-31 | $-0.04B | $0.09B | -81.19% |
| 2016-12-31 | $-0.04B | $0.10B | -133.33% |
| 2016-09-30 | $-0.06B | $0.00B | -180.95% |
| 2016-06-30 | $-0.05B | $0.01B | -150.00% |
| 2016-03-31 | $-0.04B | $0.01B | -116.67% |
| 2015-12-31 | $-0.04B | $0.11B | -98.01% |
| 2015-09-30 | $-0.01B | $0.01B | -83.58% |
| 2015-06-30 | $-0.02B | $0.02B | -75.00% |
| 2015-03-31 | $-0.02B | $0.02B | -77.11% |
| 2014-12-31 | $-0.02B | $0.02B | -72.73% |
| 2014-09-30 | $-0.01B | $0.03B | -53.01% |
| 2014-06-30 | $-0.01B | $0.02B | -59.46% |
| 2014-03-31 | $-0.01B | $0.02B | -42.11% |
| 2013-12-31 | $-0.01B | $0.02B | -31.17% |
| 2013-09-30 | $-0.01B | $0.02B | -31.82% |
| 2013-06-30 | $-0.01B | $0.02B | -22.47% |
| 2013-03-31 | $-0.01B | $0.02B | -22.22% |
| 2012-12-31 | $-0.00B | $0.03B | -13.33% |
| 2012-09-30 | $-0.01B | $0.02B | -24.69% |
| 2012-06-30 | $-0.00B | $0.02B | -14.63% |
| 2012-03-31 | $-0.00B | $0.02B | -6.56% |
| 2011-12-31 | $-0.00B | $0.02B | -42.11% |
| 2011-09-30 | $0.00B | $0.02B | 0.00% |
| 2011-06-30 | $-0.00B | $0.00B | -66.67% |
| 2011-03-31 | $-0.01B | $0.00B | -100.00% |
| 2010-12-31 | $-0.00B | $0.02B | -50.00% |
| 2010-09-30 | $-0.00B | $0.00B | inf% |
| 2010-06-30 | $0.01B | $0.00B | 350.00% |
| 2010-03-31 | $0.00B | $0.00B | 106.67% |
| 2009-12-31 | $0.00B | $0.00B | 69.57% |
| 2009-09-30 | $0.00B | $0.01B | 25.00% |
| 2009-06-30 | $-0.01B | $0.01B | -90.32% |
| 2009-03-31 | $-0.01B | $0.01B | -74.07% |
| 2008-12-31 | $-0.01B | $0.01B | -169.23% |
| 2008-09-30 | $-0.01B | $0.01B | -200.00% |
| 2008-06-30 | $-0.02B | $0.00B | -206.45% |
| 2008-03-31 | $-0.02B | $0.01B | -167.44% |
| 2007-12-31 | $-0.02B | $0.01B | -168.42% |
| 2007-09-30 | $-0.01B | $0.01B | -180.65% |
| 2007-06-30 | $-0.01B | $0.02B | -173.91% |
| 2007-03-31 | $-0.01B | $0.00B | -215.38% |
| 2006-12-31 | $-0.01B | $0.00B | -117.65% |
| 2006-09-30 | $-0.01B | $0.00B | -114.29% |
| 2006-06-30 | $-0.01B | $0.01B | -117.65% |
| 2006-03-31 | $-0.00B | $0.01B | -133.33% |
| 2005-12-31 | $-0.00B | $0.01B | -200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.135B | $0.064B |
| Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $91.495B | 21.95 |
| Intuitive Surgical (ISRG) | United States | $57.358B | 56.66 |
| Edwards Lifesciences (EW) | United States | $30.449B | 34.30 |
| Fresenius Medical Care (FMS) | Germany | $24.786B | 17.51 |
| IDEXX Laboratories (IDXX) | United States | $18.911B | 57.47 |
| ABIOMED (ABMD) | United States | $16.264B | 133.24 |
| DexCom (DXCM) | United States | $11.398B | 0.00 |
| Teleflex (TFX) | United States | $11.146B | 26.51 |
| Hologic (HOLX) | United States | $11.111B | 18.90 |
| Varian Medical Systems (VAR) | United States | $9.538B | 24.01 |
| STERIS (STE) | United Kingdom | $9.020B | 24.81 |
| Masimo (MASI) | United States | $6.006B | 39.99 |
| LivaNova (LIVN) | United Kingdom | $5.520B | 32.92 |
| Integra LifeSciences Holdings (IART) | United States | $5.328B | 27.57 |
| Globus Medical (GMED) | United States | $5.162B | 34.34 |
| Penumbra (PEN) | United States | $4.709B | 428.03 |
| Inogen (INGN) | United States | $4.171B | 110.38 |
| Cantel Medical (CMD) | United States | $3.475B | 35.01 |
| Wright Medical Group (WMGI) | Netherlands | $2.936B | 0.00 |
| Halyard Health (AVNS) | United States | $2.817B | 23.18 |
| Integer Holdings (ITGR) | United States | $2.376B | 21.52 |
| Glaukos (GKOS) | United States | $2.094B | 0.00 |
| Opko Health (OPK) | United States | $2.010B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.921B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.525B | 0.00 |
| Nevro (NVRO) | United States | $1.515B | 0.00 |
| AxoGen (AXGN) | United States | $1.284B | 0.00 |
| Luminex (LMNX) | United States | $1.267B | 37.38 |
| K2Ms (KTWO) | United States | $1.192B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.182B | 201.47 |
| CryoLife (CRY) | United States | $1.176B | 103.19 |
| Orthofix (OFIX) | United States | $1.065B | 32.44 |
| Natus Medical (BABY) | United States | $1.037B | 22.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.906B | 0.00 |
| Intersect ENT (XENT) | United States | $0.855B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.748B | 26.16 |
| ViewRay (VRAY) | United States | $0.714B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 43.21 |
| Sientra (SIEN) | United States | $0.633B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.578B | 0.00 |
| Neuronetics (STIM) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.420B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.414B | 0.00 |
| Veracyte (VCYT) | United States | $0.353B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.351B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.326B | 0.00 |
| Accuray (ARAY) | United States | $0.312B | 0.00 |
| Nuvectra (NVTR) | United States | $0.296B | 0.00 |
| Fluidigm (FLDM) | United States | $0.294B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.290B | 57.13 |
| IRadimed (IRMD) | United States | $0.277B | 99.89 |
| SeaSpine Holdings (SPNE) | United States | $0.243B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.207B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.205B | 0.00 |
| Invuity (IVTY) | United States | $0.178B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.163B | 0.00 |
| RA MEDICAL SYST (RMED) | United States | $0.162B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.133B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.123B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.110B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.105B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.101B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.090B | 0.00 |
| EDAP TMS (EDAP) | France | $0.077B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.077B | 0.00 |
| ConforMIS (CFMS) | United States | $0.059B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.056B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.046B | 0.00 |
| Neovasc (NVCN) | Canada | $0.043B | 0.00 |
| Vermillion (VRML) | United States | $0.036B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.035B | 0.00 |
| PAVmed (PAVM) | United States | $0.031B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.028B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.027B | 0.00 |
| Dynatronics (DYNT) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.023B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.022B | 0.00 |
| Presbia (LENS) | Ireland | $0.021B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.016B | 0.00 |
| Avinger (AVGR) | United States | $0.013B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.008B | 0.00 |
| Amedica (AMDA) | United States | $0.004B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
